• Mexedia raised EUR 1 million from Likan through a private placement of 1,000,000 new ordinary shares at EUR 1 per share.
• The placement is the first tranche of a fixed-price equity investment agreement signed October 29, 2026, for up to EUR 20 million.
• The new shares began trading on Euronext Growth Paris on November 5, 2026.
• The issuance diluted an existing 1% shareholder’s stake to 0.89%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mexedia S.p.A. Società Benefit published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.